<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02818400</url>
  </required_header>
  <id_info>
    <org_study_id>PHRCN06-PR-DEVAUCHELLE</org_study_id>
    <nct_id>NCT02818400</nct_id>
  </id_info>
  <brief_title>Composite Tissue Allotransplantation of the Face: Anatomical and Functional Evaluation</brief_title>
  <acronym>AFTC</acronym>
  <official_title>Composite Tissue Allotransplantation of the Face: Anatomical and Functional Evaluation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire, Amiens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire, Amiens</source>
  <brief_summary>
    <textblock>
      In hindsight, the first &quot;face graft&quot; raises the fundamental problem of composite tissue&#xD;
      allotransplantation (hand, larynx, abdominal wall, etc.) with the addition of specific&#xD;
      technical and philosophical problems.&#xD;
&#xD;
      By proposing a prospective study concerning five new patients over the next three years, in&#xD;
      the light of this first experience, the authors would like to confirm the surgical&#xD;
      feasibility of this type of procedure, possibly extending it to other parts of the face&#xD;
      (lateral third) and, like English and American teams, considering the possibility of total&#xD;
      facial surface reconstruction.&#xD;
&#xD;
      In parallel, and while complying with the usual immunosuppression procedures, the deliberate&#xD;
      choice of creating a microchimerism by the infusion of bone marrow stem cells (the origin and&#xD;
      quantity of which will need to be determined) will be reaffirmed, in order to improve&#xD;
      mucocutaneous tissue tolerance, while confirming the safety of this type of approach.&#xD;
&#xD;
      Five new cases will also provide observations for the many new fields of research developing&#xD;
      around composite tissue transplants (neurophysiology, skin histopathology, psychiatry,&#xD;
      haematology, immunology, etc.).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2009</start_date>
  <completion_date type="Anticipated">December 2024</completion_date>
  <primary_completion_date type="Anticipated">December 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>functional recovery : motor recovery</measure>
    <time_frame>1 year</time_frame>
    <description>labial contact allowing complete mouth closure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>functional recovery : sensory recovery</measure>
    <time_frame>1 year</time_frame>
    <description>Sensitivity to light touch, as assessed with the use of static monofilaments</description>
  </primary_outcome>
  <primary_outcome>
    <measure>functional recovery : sensory recovery</measure>
    <time_frame>1 year</time_frame>
    <description>sensitivity to heat and cold</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>functional recovery : motor recovery</measure>
    <time_frame>2 years, 5 years</time_frame>
    <description>labial contact allowing complete mouth closure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>functional recovery : sensory recovery</measure>
    <time_frame>2 years, 5 years</time_frame>
    <description>Sensitivity to light touch, as assessed with the use of static monofilaments</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>functional recovery : sensory recovery</measure>
    <time_frame>2 years, 5 years</time_frame>
    <description>sensitivity to heat and cold</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">5</enrollment>
  <condition>Surgery, Oral</condition>
  <arm_group>
    <arm_group_label>Composite tissue allotransplantation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>composite tissue allotransplantation</intervention_name>
    <arm_group_label>Composite tissue allotransplantation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with loss of unrepairable substance by conventional techniques shreds, at the&#xD;
             front&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Facial lesions repaired by conventional reconstructive surgery techniques&#xD;
&#xD;
          -  History of malignancy in remission for less than 5 years&#xD;
&#xD;
          -  Malignant neoplasm undergoing changes&#xD;
&#xD;
          -  Severe psychiatric history&#xD;
&#xD;
          -  Patients above a score of 2 on the scale of the ASA (American Society of&#xD;
             Anesthesiology)&#xD;
&#xD;
          -  Patients above a grade 1 in the classification NYHA ( New York Heart Association )&#xD;
&#xD;
          -  insufficient with renal creatinine clearance less than 70 mL / min or presence of a&#xD;
             proteinuria&#xD;
&#xD;
          -  Severe hypertension&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bernard DEVAUCHELLE, Md, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Amiens</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bernard DEVAUCHELLE, Md, PhD</last_name>
    <phone>+33 3 22 08 90 71</phone>
    <email>devauchelle.bernard@chu-amiens.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Amiens</name>
      <address>
        <city>Amiens</city>
        <zip>80054</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bernard DEVAUCHELLE, MD, PhD</last_name>
      <phone>+33 3 22 08 90 71</phone>
      <email>devauchelle.bernard@chu-amiens.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>June 10, 2016</study_first_submitted>
  <study_first_submitted_qc>June 27, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 29, 2016</study_first_posted>
  <last_update_submitted>August 23, 2021</last_update_submitted>
  <last_update_submitted_qc>August 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>maxillofacial surgery</keyword>
  <keyword>face graft</keyword>
  <keyword>composite tissue</keyword>
  <keyword>stem cell infusion</keyword>
  <keyword>allotransplantation</keyword>
  <keyword>microsurgery</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

